pyrroles has been researched along with Kidney, Polycystic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, M; Akiya, Y; Baba, S; Fukuda, N; Kobayashi, H; Matsumoto, T; Tsunemi, A | 1 |
| Kurth, MJ; Snyder, DS; Tradtrantip, L; Verkman, AS; Yao, C | 1 |
| Greenberg, A; Verbalis, JG | 1 |
1 review(s) available for pyrroles and Kidney, Polycystic
| Article | Year |
|---|---|
Vasopressin receptor antagonists.
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Clinical Trials as Topic; Diabetes Insipidus, Nephrogenic; Fibrosis; Heart Failure; Humans; Hyponatremia; Osmolar Concentration; Polycystic Kidney Diseases; Pyrroles; Receptors, Vasopressin; Sodium; Tolvaptan; United States; United States Food and Drug Administration; Vasopressins | 2006 |
2 other study(ies) available for pyrroles and Kidney, Polycystic
| Article | Year |
|---|---|
Development of gene silencer pyrrole-imidazole polyamides targeting GSK3β for treatment of polycystic kidney diseases.
Topics: Animals; Colforsin; Cysts; Glycogen Synthase Kinase 3 beta; Imidazoles; Kidney; Mice; Nylons; Polycystic Kidney Diseases; Polycystic Kidney, Autosomal Dominant; Pyrroles | 2023 |
Potent, metabolically stable benzopyrimido-pyrrolo-oxazine-dione (BPO) CFTR inhibitors for polycystic kidney disease.
Topics: Animals; Cystic Fibrosis Transmembrane Conductance Regulator; Kidney; Mice; Microsomes, Liver; Organ Culture Techniques; Oxazines; Polycystic Kidney Diseases; Pyrimidines; Pyrroles; Rats | 2011 |